331 related articles for article (PubMed ID: 28626726)
1. Cancer Stem Cells in Oral Cavity Squamous Cell Carcinoma: A Review.
Baillie R; Tan ST; Itinteang T
Front Oncol; 2017; 7():112. PubMed ID: 28626726
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem cells: A comprehensive review on identification and therapeutic implications.
Varun BR; Jayanthi P; Ramani P
J Oral Maxillofac Pathol; 2020; 24(1):190. PubMed ID: 32508482
[TBL] [Abstract][Full Text] [Related]
3. Cancer Stem Cell Hierarchy in Glioblastoma Multiforme.
Bradshaw A; Wickremsekera A; Tan ST; Peng L; Davis PF; Itinteang T
Front Surg; 2016; 3():21. PubMed ID: 27148537
[TBL] [Abstract][Full Text] [Related]
4. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
[TBL] [Abstract][Full Text] [Related]
5. Leading edge or tumor core: Intratumor cancer stem cell niches in oral cavity squamous cell carcinoma and their association with stem cell function.
Chowdhury FN; Reisinger J; Gomez KE; Chimed TS; Thomas CM; Le PN; Miller B; Morton JJ; Nieto CM; Somerset HL; Wang XJ; Keysar SB; Jimeno A
Oral Oncol; 2019 Nov; 98():118-124. PubMed ID: 31586893
[TBL] [Abstract][Full Text] [Related]
6. The Identification of Three Cancer Stem Cell Subpopulations within Moderately Differentiated Lip Squamous Cell Carcinoma.
Ram R; Brasch HD; Dunne JC; Davis PF; Tan ST; Itinteang T
Front Surg; 2017; 4():12. PubMed ID: 28321397
[TBL] [Abstract][Full Text] [Related]
7. RCOR1 directly binds to MED28 and weakens its inducing effect on cancer stem cell-like activity of oral cavity squamous cell carcinoma cells.
Xiang Z; Zhou S; Liang S; Zhang G; Tan Y
J Oral Pathol Med; 2020 Sep; 49(8):741-750. PubMed ID: 32306431
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Cancer Stem Cells in Moderately Differentiated Buccal Mucosal Squamous Cell Carcinoma.
Yu HH; Featherston T; Tan ST; Chibnall AM; Brasch HD; Davis PF; Itinteang T
Front Surg; 2016; 3():46. PubMed ID: 27532037
[TBL] [Abstract][Full Text] [Related]
9. Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors.
Parte SC; Batra SK; Kakar SS
J Ovarian Res; 2018 Aug; 11(1):69. PubMed ID: 30121075
[TBL] [Abstract][Full Text] [Related]
10. Cancer Stem Cells in Moderately Differentiated Buccal Mucosal Squamous Cell Carcinoma Express Components of the Renin-Angiotensin System.
Featherston T; Yu HH; Dunne JC; Chibnall AM; Brasch HD; Davis PF; Tan ST; Itinteang T
Front Surg; 2016; 3():52. PubMed ID: 27730124
[TBL] [Abstract][Full Text] [Related]
11. Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.
Kaseb HO; Fohrer-Ting H; Lewis DW; Lagasse E; Gollin SM
Exp Cell Res; 2016 Oct; 348(1):75-86. PubMed ID: 27619333
[TBL] [Abstract][Full Text] [Related]
12. Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer.
Thiagarajan PS; Hitomi M; Hale JS; Alvarado AG; Otvos B; Sinyuk M; Stoltz K; Wiechert A; Mulkearns-Hubert E; Jarrar A; Zheng Q; Thomas D; Egelhoff T; Rich JN; Liu H; Lathia JD; Reizes O
Stem Cells; 2015 Jul; 33(7):2114-2125. PubMed ID: 25827713
[TBL] [Abstract][Full Text] [Related]
13. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
Safa AR
Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
[TBL] [Abstract][Full Text] [Related]
14. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cell subpopulations in moderately differentiated head and neck cutaneous squamous cell carcinoma.
Koh SP; Brasch HD; de Jongh J; Itinteang T; Tan ST
Heliyon; 2019 Aug; 5(8):e02257. PubMed ID: 31463389
[TBL] [Abstract][Full Text] [Related]
16. Putative stem cell markers in non-small-cell lung cancer: a clinicopathologic characterization.
Sterlacci W; Savic S; Fiegl M; Obermann E; Tzankov A
J Thorac Oncol; 2014 Jan; 9(1):41-9. PubMed ID: 24346092
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of putative cancer stem cell markers (CD24, CD44, CD133, and ALDH1) in human papillary thyroid carcinoma.
Han SA; Jang JH; Won KY; Lim SJ; Song JY
Pathol Res Pract; 2017 Aug; 213(8):956-963. PubMed ID: 28687160
[TBL] [Abstract][Full Text] [Related]
18. Cancer Stem Cell Subpopulations Are Present Within Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma.
Kilmister EJ; Patel J; van Schaijik B; Bockett N; Brasch HD; Paterson E; Sim D; Davis PF; Roth IM; Itinteang T; Tan ST
Front Oncol; 2020; 10():1091. PubMed ID: 32850316
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer stem cells and intrinsic subtypes: controversies rage on.
Nakshatri H; Srour EF; Badve S
Curr Stem Cell Res Ther; 2009 Jan; 4(1):50-60. PubMed ID: 19149630
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Targeting of Cancer Stem Cells via Modulation of the Renin-Angiotensin System.
Roth IM; Wickremesekera AC; Wickremesekera SK; Davis PF; Tan ST
Front Oncol; 2019; 9():745. PubMed ID: 31440473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]